Eli Lilly's Zepbound may be best-in-breed for weight loss drugs, says Dr. Kavita Patel

Eli Lilly's Zepbound may be best-in-breed for weight loss drugs, says Dr. Kavita PatelПодробнее

Eli Lilly cuts price for weight-loss drug ZepboundПодробнее

Exclusive: How Eli Lilly’s making weight loss drugs more accessibleПодробнее

Eli Lilly goes direct-to-consumer on weight loss drugs: What patients and investors need to knowПодробнее

What is Zepbound? Weight loss drug now available, Eli Lilly saysПодробнее

Eli Lilly slashes prices of weight-loss drug Zepbound for single-use vialsПодробнее

Dr. Kavita Patel: Eli Lilly's direct-to-consumer portal will help patients get medications fasterПодробнее

FDA approves Eli Lilly's Zepbound drug for weight lossПодробнее

Eli Lilly to sell popular weight loss medication directly to consumers without insurance coverageПодробнее

Eli Lilly slashes prices of low doses of weight loss drug by scrapping auto-injectorПодробнее

Eli Lilly to offer weight loss drug directly to qualifying customers at lower priceПодробнее

Celebrities slammed for using diabetes, weight loss drugs by Eli LillyПодробнее

Eli Lilly seeks FDA approval for weight loss drug tirzepatideПодробнее

Eli Lilly warning against cosmetic use of popular weight loss drugПодробнее

Eli Lilly issues warning about potentially counterfeit weight loss drugsПодробнее

Eli Lilly releases new data from potentially game-changing weight loss drug trialПодробнее